Metabolism and action of amino acid analog anti-cancer agents

This publication has 156 references indexed in Scilit:

• Inhibition of ornithine decarboxylase induces embryonal carcinoma cell differentiation
  Biochemical and Biophysical Research Communications, 1983
• Polyamine biosynthesis and skin tumor promotion: Inhibition of 12-0-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase α-difluoromethylornithine
  Biochemical and Biophysical Research Communications, 1982
• The inhibition of γ-glutamyl transpeptidase and glutathione metabolism of isolated rat kidney cells by L-(αS, 5S)-α-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501)
  Biochemical and Biophysical Research Communications, 1980
• Irreversible inhibition of the early increase in ornithine decarboxylase activity following growth stimulation is required to block Ehrlich ascites tumor cell proliferation in culture
  Biochemical and Biophysical Research Communications, 1980
• Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis ; Effects of α-difluoromethyl- ornithine, an irreversible inhibitor or ornithine decarboxylase
  Life Sciences, 1980
• Anti-proliferative properties of DL-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase
  Biochemical and Biophysical Research Communications, 1978
• The stoichiometric fate of azaserine metabolized in vitro by tissues from azaserine-treated dogs and mice*1
  Toxicology and Applied Pharmacology, 1972
• 6-Diazo-5-oxo-L-norleucine, A New Tumor-inhibitory Substance. II.¹ Isolation and Characterization²
  Journal of the American Chemical Society, 1956
• Azaserine, a New Tumor-inhibitory Substance. Structural Studies.¹
  Journal of the American Chemical Society, 1954
• Azaserine, a New Tumor-inhibitory Substance. Isolation and Characterization¹
  Journal of the American Chemical Society, 1954